Docket
117th Congress · HOUSE BILLBILL

H.R. 2869 — Increasing Access to Biosimilars Act of 2021

“To require the Secretary of Health and Human Services to establish a demonstration project to increase access to biosimilar biological products under the Medicare program.”

Health
Introduced Apr 28, 2021
Last action Apr 29, 2021
Pipeline · Bill → Law
Step 1
Introduced
Apr 28, 2021
Step 2
Referred
Apr 29, 2021
E&C · Ways & Means
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in House
Timeline · 5 actions
Apr 29, 2021
Referred to the Subcommittee on Health.
Apr 28, 2021
Introduced in House
Apr 28, 2021
Referred to the Subcommittee on Health.
Apr 28, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 28, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.